Akiko Emi

Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy

Ai Amioka, Norio Masumoto, N Gouda et al. · Japanese Journal of Clinical Oncology · 2016 · 51 citations · Full text

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer – Usefulness for malignant grade of triple-negative breast cancer

Masahiro Ohara, Hideo Shigematsu, Yasuhiro Tsutani et al. · The Breast · 2013 · 44 citations · Full text

Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy

Etsushi Akimoto, Takayuki Kadoya, Keiko Kajitani et al. · Clinical Breast Cancer · 2017 · 33 citations

The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial

Hideo Shigematsu, Takayuki Kadoya, Norio Masumoto et al. · Clinical Breast Cancer · 2014 · 30 citations

Resectable Breast Cancer, Surgical Oncology, Breast Oncology +10

Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT

Shinsuke Sasada, Norio Masumoto, Eri Suzuki et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 28 citations

Positron Emission Tomography, Radiation Oncology, Engineering +12